An oral tablet formulation of zanubrutinib was approved for use in patients with certain lymphomas or leukemia and ...

UroGen Pharma received Food and Drug Administration approval for bladder cancer drug Zusduri, previously known as UGN-102. The company expects the drug will be available on or about July 1. It was ...

The U.S. Food and Drug Administration on Thursday approved UroGen Pharma's drug to treat a type of bladder cancer. The ...

The Food and Drug Administration said approved UroGen Pharma’s (URGN) Zusduri for adult patients with recurrent low-grade intermediate-risk ...

FDA approves new Brukinsa tablet for five blood cancers, offering simpler dosing with the same safety and effectiveness as ...

AI may provide an answer to the question of whether drugs initially developed and prescribed for non-neurodegenerative physical conditions can be used to treat individuals with Parkinson’s disease.

Retifanlimab-dlwr (Zynyz) was granted approval from the FDA for treatment of locally recurrent or metastatic squamous cell ...

Here is a recap of every FDA approval announced by the regulatory agency in the month of May, spanning various cancer types.

Darolutamide (Nubeqa) is granted FDA approval for metastatic castration-sensitive prostate cancer, enhancing survival and ...

FDA approved Merck's Welireg as the first oral therapy for advanced pheochromocytoma or paraganglioma (PPGL). In the LITESPARK-015 trial, Welireg showed a 26% ORR and a 20.4-month median duration ...

Verastem said the combination treatment, branded as Avmapki Fakzynja Co-pack, will be available in one week at a list ... only approval for a drug to treat adults with this form of cancer, called ...

In a separate announcement, the drug co-developer Sino Biopharmaceutical also noted FDA approval of the marketing of penpulimab. NPC, a type of head and neck cancer ... 20 on a list of China ...